Research keywords (4)：
医療薬学
, 腎臓病薬物療法
, 腎障害
, 薬学教育
Research theme for competitive and other funds (7)：
2023 - 2026 Establish a preventive strategy against thromboembolism in chronic kidney disease by suppressing indoxyl sulfate production and accumulation.
2022 - 2025 Investigation of toxicological role of indoxyl sulfate and its production responsible enzyme Sult1a1 in cardiorenal syndrome
2015 - 2018 Optimization of combination therapy with antihypertensive drug to ameliorate side effects of multilinase inhibitors in kidney cancer
2014 - 新たな治療戦略を目指したCKD治療薬としてのカモスタットの有用性評価
Show all
Papers (32)：
Sara Utsumi, Yuki Kondo, Yoshihiko Harada, Akira Yoshida, Hiroyuki Nishimura, Yuki Narita, Tetsumi Irie, Hideaki Jinnouchi, Yoichi Ishitsuka, Sumio Hirata. Evaluation of a creatinine clearance correction equation based on body fat mass in older Japanese patients with diabetes. Frontiers in Medicine. 2024. 11
Yasunobu Iwata, Qinyuan Deng, Yutaka Kakizoe, Terumasa Nakagawa, Yoshikazu Miyasato, Miyuki Nakagawa, Kayo Nishiguchi, Yu Nagayoshi, Yuki Narita, Yuichiro Izumi, et al. A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats. International journal of molecular sciences. 2023. 24. 21
Huixian Hou, Mai Horikawa, Yuki Narita, Hirofumi Jono, Yutaka Kakizoe, Yuichiro Izumi, Takashige Kuwabara, Masashi Mukoyama, Hideyuki Saito. Suppression of Indoxyl Sulfate Accumulation Reduces Renal Fibrosis in Sulfotransferase 1a1-Deficient Mice. International journal of molecular sciences. 2023. 24. 14
Qinyuan Deng, Yutaka Kakizoe, Yasunobu Iwata, Terumasa Nakagawa, Yoshikazu Miyasato, Miyuki Nakagawa, Kayo Nishiguchi, Yu Nagayoshi, Masataka Adachi, Yuki Narita, et al. The serine protease plasmin plays detrimental roles in epithelial sodium channel activation and podocyte injury in Dahl salt-sensitive rats. Hypertension research : official journal of the Japanese Society of Hypertension. 2022. 46. 1. 50-62
Novel drug therapy targeting NF-kB signal for triple-negative breast cancer patients with loss of CYLD expression
(日本薬学会年会要旨集(Web) 2023)
Clinical significance and development of novel therapies for advanced ovarian cancer with loss of tumor suppressor gene CYLD expression
(日本薬学会年会要旨集(Web) 2023)
2009 - 2011 Kumamoto University Graduate School of Pharmaceutical Sciences
2005 - 2009 Tokyo University of Science Faculty of Pharmaceutical Sciences
Professional career (1)：
博士(薬学) (熊本大学)
Work history (2)：
2019/04 - 現在 Kumamoto University
2011/04 - 2019/03 Kumamoto University School of Pharmacy
Committee career (5)：
2023/04 - 現在 熊本県腎臓病療養指導士連絡協議会 幹事
2022/10 - 現在 日本腎臓病薬物療法学会 代議員
2022/07 - 現在 日本病院薬剤師会 編集委員
2019/04 - 現在 熊本県病院薬剤師会 実務実習WG委員
2012 - 現在 熊本腎と薬剤研究会 評議員
Awards (6)：
2021/10 - 公共財団法人肥後医育振興会 肥後医育振興会学術奨励賞
2021/06 - 日本医療薬学会 Postdoctoral Award
2019/07 - 第5回日本医薬品安全性学会学術大会 優秀ポスター賞
2018/11 - 第12回日本腎臓病薬物療法学会学術集会・総会 優秀演題賞
2018 - 熊本大学 平成30年度熊本大学教育活動表彰
2012 - 熊本大学 平成24年度熊本大学学部・大学院教育活動表彰
Show all
Association Membership(s) (6)：
日本臨床薬理学会
, JAPANESE SOCIETY OF NEPHROLOGY
, 日本病院薬剤師会
, 日本腎臓病薬物療法学会
, THE PHARMACEUTICAL SOCIETY OF JAPAN
, JAPANESE SOCIETY OF PHARMACEUTICAL HEALTH CARE AND SCIENCES
